Additionally, glioma-derived CCL2 recruits TAMs to the tumor [52], but at the same time takes part in a feed-forward mechanism, where it induces IL-6 production in microglia, which consecutively affects glioma cells by increasing their invasiveness [53]. The gene discussed is IL6; the disease is central nervous system cancer.